Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease

American Journal of Pathology

Volumn 157, Issue 4, 2000, Pages 1105-1111

  Maitra, A ^a   Molberg, K ^a   Albores Saavedra, J ^a   Lindberg, G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; COLON ADENOCARCINOMA; COLON ADENOMA; FEMALE; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN TISSUE; LYMPH NODE; MALE; METASTASIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0033814963     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64625-1     Document Type: Article

References (39)

1. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
2. Frequency of Smad gene mutations in human cancers
3. Identification of a chromosome 18q gene that is altered in colorectal cancers
4. Homozygous deletion map at 18q21.1 in pancreatic cancer
5. Genetic alterations during colorectal-tumor development
6. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers
7. Tumor-suppressor genes in pancreatic cancer
8. Mutations in the SMAD4/DPC4 gene in juvenile polyposis
9. Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases
10. Frequent 4-bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients
11. SMAD4 germline mutations in juvenile polyposis coli
12. Intestinal tumorigenesis in compound mutant mice of both Dpc4(smad4) and Apc genes
13. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis
14. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation
15. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression
16. Prognosis of node-positive colon cancer
17. A genetic model for colorectal tumorigenesis
18. Prevalence of ras gene mutations in human colorectal cancers
19. Localization of the gene for familial adenomatous polyposis on chromosome 5
20. The gene for familial polyposis coli maps to the long arm of chromosome 5
21. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
22. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients
23. Intracellular signaling of the TGF-beta superfamily by Smad proteins
24. Cancer gets Mad: DPC4 and other TGFbeta pathway genes in human cancer
25. Inactivation of Smad4 in gastric carcinomas
26. Involvement of mutations in the DPC4 promoter in endometrial carcinoma development
27. Smad2 and Smad4 gene mutations in hepatocellular carcinoma
28. MAD-related genes on 18q21.1, Smad2 and Smad4, are altered infrequently in esophageal squamous cell carcinoma
29. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas
30. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo
31. Frequent allelic imbalance on chromosome 18q21 in early superficial colorectal cancers
32. Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: Identification of seven novel somatic mutations in tumors from Japanese patients
33. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination
34. Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms
35. DPC4 gene mutation in colitis associated neoplasia
36. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis
37. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice
38. Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomas
39. Orthotopic models of human pancreatic cancer